ISSN 1518 0557
IUI needs fairer appraisal to improve patient and stakeholder choices

2021; 25
Gulam Bahadur, Bryan Woodward, Megan Carr, Santanu Acharya, Asif Muneer, Roy Homburg
JBRA Assist. Reprod. 2021; 25 (1):162-164

Received April 04, 2020
Accepted October 02, 2020
Abstract

Information supporting IVF at the expense of intrauterine insemination (IUI) has become commonplace but lacks critical analysis. Data from poorly practiced IUI, without an equivalent comparison to IVF, has been generalised to recommend a total abandonment of IUI in favour of IVF treatment.. Our intention with this paper is to reappraise and balance and arguments so that patients and stakeholders can have an unbiased informed choice. We provide information that reveals IUI is dominant over IVF in terms of integrated success, risks and cost to deliver one live birth whilst obviating the maternal and neonatal costs. Exceptional cost savings are demonstrated for IUI over IVF for fee-paying agencies and patients with lowered risks of maternal and neonatal care along with other risks including OHSS, fetal reduction and termination of pregnancies. This analysis supports the view that patients and stakeholders can choose IUI before IVF in most instances except with bilateral tubal blockage and severe male factor infertility. It is apparent that fertility clinics need to re-evaluate and reconsider this area as well practiced IUI can be of benefit to both subfertile patients and the stakeholders.


This Article

doi: 10.5935/1518-0557.20200066

Full Text (HTML)
Full Text (PDF)

Classifications

Update or opinion article

How to cite

How to cite this article

Send this article

Send this article by mail

Access statistics

Last 30 days: 49
All time: 2603


Home

 
Copyright 2026 - JBRA Assisted Reproduction - All rights reserved.
Support and Maintenance by Eniosoft